Get started
Author

Nanne Aben

Observed names: Aben Nanne, Aben, N, Aben, N.N., Aben, Nanne, N. Aben
OpenAlex ID: A5075471491
A Landscape of Pharmacogenomic Interactions in Cancer
2016 · Francesco Iorio, Theo A. Knijnenburg, et al. · Cell · 2,076
PDF
Effective drug combinations in breast, colon and pancreatic cancer cells
2022 · Patricia Jaaks, Elizabeth A. Coker, et al. · Nature · 465
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
2019 · Michael P. Menden, Dennis Wang, et al. · Nature Communications · 362
PDF
Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells
2017 · Theodoros I. Roumeliotis, Steven P. Williams, et al. · Cell Reports · 115
PDF
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
2016 · Nanne Aben, Daniel J Vis, et al. · Bioinformatics · 77
PDF
Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2019 · Remco Nagel, Ana Teresa Avelar, et al. · Molecular Cancer Therapeutics · 36
Principal component analysis of binary genomics data
2017 · Yipeng Song, Johan A Westerhuis, et al. · Briefings in Bioinformatics · 32
Mortality in Severe Human Immunodeficiency Virus-Tuberculosis Associates With Innate Immune Activation and Dysfunction of Monocytes
2017 · Saskia Janssen, Charlotte Schutz, et al. · Clinical Infectious Diseases · 32
PDF
iTOP: inferring the topology of omics data
2018 · Nanne Aben, Johan A Westerhuis, et al. · Bioinformatics · 20
PDF
Towards Large-Scale Training of Pathology Foundation Models
2024 · ai, kaiko., Aben, Nanne, et al. · arXiv (Cornell University) · 12
PDF
A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level
2024 · Daniel J. Vis, Patricia Jaaks, et al. · Cell Reports Medicine · 11
Heterofusion: Fusing genomics data of different measurement scales
2020 · Age K. Smilde, Yipeng Song, et al. · Journal of Chemometrics · 10
PDF
Generalized simultaneous component analysis of binary and quantitative data
2020 · Yipeng Song, Johan A. Westerhuis, et al. · Journal of Chemometrics · 9
PDF
Active WeaSuL: Improving Weak Supervision with Active Learning
2021 · Biegel, Samantha, El-Khatib, Rafah, et al. · arXiv (Cornell University) · 7
PDF
Highlights from the ISCB Student Council Symposia in 2016
2016 · Bart Cuypers, Annika Jacobsen, et al. · F1000Research · 6
PDF
Enhancing Data Completeness in Early Detection Pathway of Prostate Cancer: Integration of a Dashboard-Driven Feedback Tool to Improve Quality of Care
2024 · Lucas C. van Maaren, Nanne Aben, et al. · Journal of Clinical Medicine · 4
PDF
Identifying biomarkers of anti-cancer drug synergy using multi-task learning
2018 · Nanne Aben, Julian R. de Ruiter, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Validating large language model–assisted data extraction from clinical notes
2026 · J.W. van Koevorden, N. Aben, et al. · ESMO Real World Data and Digital Oncology · 1
PDF
A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination
2017 · Marco Ranzani, Kristel Kemper, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
TANDEM: A Two-Stage Approach to Maximize Interpretability of Drug Response Models Based on Multiple Molecular Data Types
2016 · Nanne Aben · 1
PDF
AI-supported first consultation preparation in oncology: a real-world clinical usability study
2026 · Josephine W. van Koevorden, Rachael Mertooetomo, et al. · npj Digital Medicine
PDF
359P Validating large language model-assisted data extraction from clinical notes in head and neck oncology
2025 · J.W. Van Koevorden, N. Aben, et al. · ESMO Real World Data and Digital Oncology
Advancing prostate cancer risk stratification: Is predicting positive Magnetic Resonance Imaging (MRI) findings the preferred approach?
2024 · M.J. Hagens, L.S. Mertens, et al. · European Urology
Supplementary Tables 1-6 from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023 · Remco Nagel, Ana Teresa Avelar, et al.
Supplementary Figure 1C + D from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023 · Remco Nagel, Ana Teresa Avelar, et al.
PDF
Works count: 57
Citation count: 3,278
H-index: 11
I10-index: 12
Year
Topic
Type